BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
BEGIN:VEVENT
DTSTAMP:20260808T230046Z
UID:ee9b0b12-85b4-4f97-b964-163211f301ad
DTSTART:20171114T090000Z
DTEND:20171114T000000Z
DESCRIPTION:\nThe implementation of cancer genomics into the clinic is beco
 ming a reality. Personalized medicine or Precision medicine as other autho
 rs refers\, uses molecular data of a specific patient to guide clinical de
 cisions such as prevention\, diagnosis and treatment. This will revolution
 ize healthcare and will play a dominant role in the future of cancer thera
 py. Bioinformatics analyses are essential to identify patients who will be
 nefit from treatment based on their molecular profile\, and to tailor chem
 otherapeutic regimens accordingly.\n\nThe aim of the course is to present 
 a complete computational pipeline for the analysis and interpretation of N
 ext-Generation Sequencing (NGS) data such as exome sequencing or targeted 
 panels that are commonly used in the clinic.\n\nWe will address the implem
 entation of large-scale genomic sequencing in clinical practice and the re
 cently developed computational strategies for the analysis of NGS data wit
 h a particular emphasis on the interpretation of the results\, selection o
 f biomarkers of drug response and afford opportunities to match therapies 
 with the characteristics of the individual patient's tumour. \n\nExercise
 s and case studies focused on cancer will be used to illustrate the princi
 ples of how genetics influence led to refining diagnoses and personalized 
 treatment of cancer disease.\nTarget Audience:\nThis course is intended fo
 r working healthcare professionals and Bioinformaticians working in the ar
 ea.\nCourse Pre-Requisites:\nThe course assumes that attendees are not int
 imidated by the prospect of gaining experience working on UNIX-like operat
 ing systems (including the shell\, and shell scripting). Attendees should 
 understand some of the science behind high-throughput DNA sequencing and s
 equence analysis\, as we will not go deeply into underlying theory (or the
  mechanics of given algorithms\, for example) as such. What will be taught
  are technical solutions for automating and sharing such analyses in reusa
 ble compute environments\, which will include (but is not limited to) begi
 nner-level programming\, and basic Linux provisioning. General computer li
 teracy\, (e.g. editing plain text data files\, navigating using the comman
 d line) will be assumed. (*) \n(*) Note: An optional free session will b
 e arranged with the participants that may be interested\, on the EVE of th
 e first day (Monday\, Nov 13th at 4PM)\, where we will ensure that every p
 articipant willing to attend can use the Linux operating system at the req
 uired level.\nInstructors:​\n           \nFátima Al-Shahrour obt
 ained her PhD from Universidad Autónoma de Madrid (UAM) in 2006. During h
 er PhD she worked at the Bioinformatics Unit at Spanish National Cancer Re
 search Center (CNIO\, Madrid\, Spain) and Centro de Investigaciones Prínc
 ipe Valencia (Valencia\, Spain). During this period\, her research work de
 alt with the development of new Bioinformatics tools for microarray gene e
 xpression analysis\, with a particular focus on computational methods for 
 the functional interpretation of high-throughput experiments. In 2007\, sh
 e joined the Computational Biology and Bioinformatics group at Cancer Prog
 ram at Broad Institute of Massachusetts Institute of Technology (MIT) and 
 Harvard (Cambridge\, USA). In 2008\, she got a staff position at Broad Ins
 titute of MIT and Harvard as a Computational Biologist. During this period
 \, her research was focused on the study the biology and treatment of canc
 er under a genomic perspective using hematopoiesis as a model system. In 2
 012 she joined the Spanish National Cancer Research Centre (CNIO) to lead 
 the Translational Bioinformatics Unit (TBU) in the Clinical Research Progr
 amme and since 2017 she is leading the Bioinformatics Unit (BU).\n	--\n	Th
 e CNIO Bioinformatics Unit (BU) belongs to the Structural and Biocomputing
  Programme. This is a group with a large trajectory in bioinformatics for 
 functional genomics\, field in which the group has published numerous pape
 rs as well as developed distinct applications and programs widely used by 
 the scientific community. BU's major research activity is focused on the d
 evelopment of new computational methodologies to perform genomic analysis 
 of cancer patients' data\, in order to identify new biomarkers and mechani
 sms of drug response. The main goal is to translate this knowledge into ef
 fective treatments for cancer patients. Since 2013\, we extensively collab
 orate with hospitals to analyze next-generation sequencing data from patie
 nt's tumors. During this period\, we have applied our analytical pipeline 
 for the categorization and interpretation of patient's tumors and match th
 em to effective drugs or treatments based on their genomic alterations.\n
            Affiliation: Centro Nacional de Investigaciones Oncológ
 icas\, Madrid\, ES\nJavier Perales is a PhD student working under the sup
 ervision of Fátima Al-Shahrour &amp\; Alfonso Valencia\, at the Spanish N
 ational Cancer Research Centre. During his education\, he has acquired kno
 wledge in Molecular Biology\, Genetics and Computational Biology. His rese
 arch activity is focused on the genomic characterization of patient tumour
 s by Next-Generation Sequencing technologies. He is interested on the deve
 lopment and integration of computational approaches for cancer genomics da
 ta in order to improve our understanding about the individual patient's di
 sease.\n           Affiliation: Centro Nacional de Investigaciones 
 Oncológicas\, Madrid\, ES\nElena Piñeiro is a Bioinformatician working 
 in the Bioinformatics Unit of the CNIO. Her work is mainly focused on the 
 elaboration of pipelines for the analysis and prioritization of genomic va
 riations obtained through NGS technologies and on the construction of a me
 thodology for the personalized drug assignation according to the particula
 r genomic profile of each patient.\n           Affiliation: Centro 
 Nacional de Investigaciones Oncológicas\, Madrid\, ES\n \nProgram:\nYou 
 can find here the detailed program.\n \nRegistration: \nRegister using h
 ere until October the 18th\n \nContact: For any questions about this co
 urse\, please contact Pedro Fernandes (e-mail address below)
LOCATION:Instituto Gulbenkian de Ciência
SUMMARY:PM17 - Precision Medicine
URL;VALUE=URI:http://gtpb.igc.gulbenkian.pt/bicourses/PM17/
END:VEVENT
END:VCALENDAR
